385 related articles for article (PubMed ID: 17867974)
1. Pharmacokinetics of an extended-release theophylline product in cats.
Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
Bach JE; Kukanich B; Papich MG; McKiernan BC
J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets].
Heusinger JH; Breuel HP; Behrendt WA; Wolfstädter HD
Fortschr Med; 1989 Nov; 107(32):692-6. PubMed ID: 2689314
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
6. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
7. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cetirizine in healthy cats.
Papich MG; Schooley EK; Reinero CR
Am J Vet Res; 2008 May; 69(5):670-4. PubMed ID: 18447800
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man.
Sharma PL; Sharma RM
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):394-6. PubMed ID: 583044
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats.
Carnes MB; Axlund TW; Boothe DM
Am J Vet Res; 2011 Sep; 72(9):1247-52. PubMed ID: 21879984
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
14. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
[TBL] [Abstract][Full Text] [Related]
15. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
17. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability and bioequivalence study of theophylline sustained release formulations.
Vergin H; Mahr G; Winterhalter B; Wigand R
Arzneimittelforschung; 2003; 53(9):635-9. PubMed ID: 14558437
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of controlled-release carbimazole tablets support once daily dosing in cats.
Frénais R; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2008 Jun; 31(3):213-9. PubMed ID: 18471142
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
